B
2,210
+1.14%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in KRW, from our data supplier.
Revenue
₩95.90bn
FY2016FY2025
Net income
₩2.84bn
FY2016FY2025
Free cash flow
−₩1.95bn
FY2016FY2025
Shareholders' equity
₩233.70bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₩95.90bn | ₩89.23bn | ₩81.00bn | ₩42.30bn | ₩25.25bn | ₩19.44bn | ₩17.67bn | — | — | — |
| Gross profit | ₩39.38bn | ₩41.75bn | ₩44.43bn | ₩23.62bn | ₩13.10bn | ₩10.67bn | ₩10.48bn | — | — | — |
| Research and development | ₩5.14bn | ₩2.71bn | ₩4.97bn | ₩5.40bn | ₩8.88bn | ₩1.70bn | — | — | — | — |
| Operating income | ₩1.73bn | ₩10.59bn | ₩8.01bn | −₩10.10bn | — | ₩947.9m | ₩1.48bn | −₩39.5m | −₩42.2m | −₩16.8m |
| Net income | ₩2.84bn | ₩13.31bn | ₩25.69bn | −₩44.70bn | −₩176.27bn | ₩1.42bn | −₩5.40bn | ₩159.1m | ₩106.2m | −₩11.9m |
| Diluted earnings per share | 41.47 | 200.28 | 387.05 | -676.99 | -3,257.80 | 26.30 | -145.67 | 21.52 | 14.36 | -1.61 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | ₩277.99bn | ₩267.07bn | ₩236.15bn | ₩232.52bn | ₩134.71bn | ₩67.62bn | ₩49.60bn | ₩15.08bn | ₩14.90bn | ₩14.97bn |
| Cash and short-term investments | — | — | ₩81.75bn | ₩118.68bn | ₩32.07bn | ₩7.43bn | ₩22.40bn | ₩1.72bn | ₩1.73bn | ₩14.96bn |
| Total liabilities | ₩38.45bn | ₩30.58bn | ₩26.62bn | ₩48.57bn | ₩84.05bn | ₩30.63bn | ₩22.02bn | ₩1.60bn | ₩1.57bn | ₩1.74bn |
| Debt | ₩20.00bn | ₩7.90bn | ₩737.2m | ₩1.33bn | ₩29.18bn | ₩24.67bn | ₩15.78bn | ₩1.57bn | ₩1.54bn | ₩1.51bn |
| Shareholders' equity | ₩233.70bn | ₩229.87bn | ₩209.53bn | ₩183.95bn | ₩50.66bn | ₩36.99bn | ₩27.58bn | ₩13.49bn | ₩13.33bn | ₩13.22bn |
| Shares outstanding | 68m | 66m | 66m | 66m | 54m | 54m | 37m | 7m | 7m | 7m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | ₩7.16bn | ₩16.70bn | ₩16.43bn | −₩5.51bn | −₩11.27bn | ₩3.85bn | ₩3.78bn | ₩1.93bn | −₩80.3m | ₩186.0m |
| Capital spending | −₩9.11bn | −₩18.08bn | −₩8.25bn | −₩19.19bn | −₩8.41bn | −₩31.63bn | −₩7.82bn | −₩5.51bn | −₩5.51bn | — |
| Free cash flow | −₩1.95bn | −₩1.39bn | ₩8.18bn | −₩24.70bn | −₩19.68bn | −₩27.77bn | −₩4.04bn | −₩3.58bn | −₩5.59bn | ₩186.0m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩24.61bn | ₩20.73bn | ₩23.57bn | ₩22.28bn | ₩24.63bn | ₩25.42bn | ₩25.78bn | ₩23.51bn |
| Gross profit | ₩9.03bn | ₩7.82bn | ₩7.52bn | ₩8.75bn | ₩10.75bn | ₩15.01bn | ₩10.80bn | ₩14.20bn |
| Operating income | −₩366.3m | −₩1.48bn | −₩2.25bn | −₩1.40bn | ₩1.59bn | ₩3.80bn | ₩1.72bn | ₩3.41bn |
| Net income | −₩1.13bn | −₩1.03bn | −₩2.37bn | −₩187.4m | ₩336.3m | ₩5.06bn | ₩8.55bn | ₩1.83bn |
| Diluted earnings per share | -16.52 | -15.12 | -34.62 | -2.74 | 4.92 | 73.92 | 125.94 | 27.53 |
| Cash from operations | ₩4.66bn | ₩2.67bn | ₩2.64bn | −₩2.02bn | ₩2.77bn | ₩3.78bn | ₩16.70bn | ₩11.04bn |
| Capital spending | −₩1.32bn | −₩665.0m | −₩2.36bn | −₩1.31bn | −₩2.79bn | −₩2.64bn | −₩18.08bn | −₩11.16bn |
| Free cash flow | ₩3.33bn | ₩2.00bn | ₩274.0m | −₩3.34bn | −₩23.0m | ₩1.14bn | −₩1.39bn | −₩118.0m |
| Total assets | ₩272.49bn | ₩276.62bn | ₩277.99bn | ₩282.67bn | ₩281.85bn | ₩271.11bn | ₩267.07bn | ₩249.98bn |
| Cash and short-term investments | — | — | — | — | — | — | — | ₩84.32bn |
| Debt | — | ₩14.00bn | ₩20.00bn | ₩18.88bn | ₩18.88bn | ₩8.80bn | ₩7.90bn | ₩11.43bn |
| Shareholders' equity | ₩226.76bn | ₩227.87bn | ₩233.70bn | ₩236.09bn | ₩236.25bn | ₩235.92bn | ₩229.87bn | ₩214.30bn |
Financial ratios
Data as of 2 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Gross margin | 41.1% | 46.8% | 54.9% | 55.8% | 51.9% | 54.9% | — |
| Operating margin | 1.8% | 11.9% | 9.9% | -23.9% | — | 4.9% | 13.2% |
| Net margin | 3.0% | 14.9% | 31.7% | -105.7% | -698.1% | 7.3% | — |
| Return on equity | 1.2% | 5.8% | 12.3% | -24.3% | -347.9% | 3.8% | — |
| Return on assets | 1.0% | 5.0% | 10.9% | -19.2% | -130.8% | 2.1% | — |
| Free cash flow yield | — | — | 14.0% | 7.8% | -2.0% | 24.6% | 11.8% |
| Revenue growth | 7.5% | 10.2% | 91.5% | 67.5% | 29.9% | 10.0% | — |
| Earnings growth | -78.7% | -48.2% | -157.5% | -74.6% | -12476.3% | -126.4% | — |
| Current ratio | 8.97x | 6.41x | 7.32x | 9.97x | 2.12x | 0.73x | — |
| Debt to equity | 0.09x | 0.03x | 0.00x | 0.07x | 0.57x | 0.65x | — |
| Equity ratio | 84.1% | 86.1% | 88.7% | 79.1% | 37.6% | 54.7% | — |
| Interest coverage | 2.75x | 31.66x | 11.79x | -5.30x | — | 9.07x | — |
| R&D as a share of sales | 5.4% | 3.0% | 6.1% | 12.8% | 35.2% | 8.7% | — |
| Buybacks as a share of market value | — | — | -0.5% | -22.0% | 0.1% | -46.1% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 31.4% | 37.6% | — |
| Operating income | — | 12.8% | — |
| Net income | — | 14.8% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 43.8% | 48.4% | 49.0% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 108.0 | 20.7 | 9.6 | -6.9 | -8.2 | 153.5 | -11.3 | 90.2 | 130.9 |
| Price to sales | 3.2 | 3.1 | 3.0 | 7.3 | 56.9 | 11.3 | 3.4 | — | — |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 1231-for-1136 split · 25 Jan 2022
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.